AI Summary
This grant opportunity, PAR-25-111, focuses on translational research in maternal and pediatric pharmacology and therapeutics. It is an R21 Clinical Trial Optional grant, and funding is available through CFDA numbers 93.865, 93.855, 93.279, and 93.313.